MedPath

1-1-12 Wash-in for Desflurane Low Flow Anesthesia

Completed
Conditions
Anesthesia
Interventions
Procedure: 1-1-12 wash-in
Registration Number
NCT02013882
Lead Sponsor
Khon Kaen University
Brief Summary

We propose a new wash-in technique for desflurane low flow anesthesia with fresh gas flow of O2:N2O 1:1 L/min with desfluraene 12%.

The objective of this study is to identify time to achieve alveolar concentration of desflurane at1, 2, 3, 4, 5 and 6%.

Detailed Description

The benefits of low flow anesthesia are economic, less pollution, more heat and humidity preservation but it requires appropriate wash-in phase. The current wash-in protocols are complicated and time consuming. We propose a new 1-1-12 desflurane wash-in protocol which is more simple and predictable.

The objective of this study is to identify time to achieve alveolar concentration of desflurane at 1, 2, 3, 4, 5 and 6% with 1-1-12 wash-in protocol.

All patients will receive iv propofol 2 mg/kg as induction agent and succinyl choline 1.5 mg/kg for intubation. Then the ventilation will be controlled to achieve end-tidal CO2 30-35 mmHg with O2:N2O 1:1 L/min with desflurane 12%. Time to achieve alveolar concentration of desflurane at 1, 2, 3, 4, 5 and 6% will be recorded and analyzed. After that, the concentration of desflurane and anesthetic technique will be adjusted to requirement of anesthesiologist.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
106
Inclusion Criteria
  • ASA classification I-II
  • age 18-64 years
Exclusion Criteria
  • BMI > 35
  • contraindicated for N2O
  • with pulmonary or cardiac disease

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
1-1-12 wash-in1-1-12 wash-inwash-in using O2:N2O 1:1 L/min with desflurane 12%
Primary Outcome Measures
NameTimeMethod
Time (in second) to achieve alveolar concentration of desflurane 1, 2, 3, 4, 5 and 6%participants will be followed until alveolar concentration of desflurane reaches 6%, as expected of 15 minutes
Secondary Outcome Measures
NameTimeMethod
Heart rateparticipants will be followed until alveolar concentration of desflurane reaches 6%, as expected of 15 minutes

Trial Locations

Locations (1)

Srinagarind Hospital

🇹🇭

Khon Kaen, Thailand

© Copyright 2025. All Rights Reserved by MedPath